Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy.

Autor:	Orsi FA; Faculdade de Ciências Médicas da Universidade Estadual de Campinas (FCM-Unicamp), Campinas, SP, Brazil. Electronic address: ferorsi@unicamp.br., De Paula EV; Centro de Hematologia e Hemoterapia da Universidade Estadual de Campinas (Hemocentro-Unicamp), Campinas, SP, Brazil., Santos FO; AC Camargo Cancer Center, São Paulo, SP, Brazil; Hospital 9 de Julho, São Paulo, SP, Brazil., Teruchkin MM; Laboratório de Doenças Vasculares do Hospital Moinhos de Vento, Porto Alegre, RS, Brazil., Campêlo DHC; Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil., Mello TT; Instituto de Hematologia, Hemostasia e Trombose (IHHT), Campinas, SP, Brazil., Chindamo MC; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil; Barra D'Or Hospital, Rede D'Or São Luiz, Rio de Janeiro, RJ, Brazil., Macedo AVS; Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil; Hospital Sao Luiz Jabaquara, São Paulo, SP, Brazil., Rocha AT; Faculdade de Medicina da Bahia da Universidade Federal da Bahia (FMB-UFBA), Salvador, BA, Brazil; Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brazil., Ramacciotti E; Faculdade de Ciências Médicas da Santa Casa de São Paulo (FCMSCSP), São Paulo, SP, Brazil; Hospital Christóvão da Gama, Grupo Leforte, Santo André, SP, Brazil; Loyola University Medical Center, Maywood, IL, United States., Nascimento ACK; Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil., Annichino-Bizzacchi J; Centro de Hematologia e Hemoterapia da Universidade Estadual de Campinas (Hemocentro-Unicamp), Campinas, SP, Brazil., Lourenco DM; Universidade Federal de São Paulo (USP), São Paulo, SP, Brazil., Guerra JCC; Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil; Centro de Hematologia de São Paulo (CHSP), São Paulo, SP, Brazil., Rezende SM; Faculdade de Medicina da Universidade Federal de Minas Gerais (FM/UFMG), Belo Horizonte, MG, Brazil., Cavalheiro Filho C; Hospital Sírio-libanês, São Paulo, SP, Brazil; Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (Incor FMUSP), São Paulo, SP, Brazil.
Jazyk:	angličtina
Zdroj:	Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2020 Oct - Dec; Vol. 42 (4), pp. 300-308. Date of Electronic Publication: 2020 Jun 13.
DOI:	10.1016/j.htct.2020.06.001
Abstrakt:	Hemostatic abnormalities and thrombotic risk associated with coronavirus disease 2019 (COVID-19) are among the most discussed topics in the management of this disease. The aim of this position paper is to provide the opinion of Brazilian experts on the thromboprophylaxis and management of thrombotic events in patients with suspected COVID-19, in the sphere of healthcare in Brazil. To do so, the Brazilian Society of Thrombosis and Hemostasis (BSTH) and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH) have constituted a panel of experts to carefully review and discuss the available evidence about this topic. The data discussed in this document was reviewed by May 9, 2020. Recommendations and suggestions reflect the opinion of the panel and should be reviewed periodically as new evidence emerges. (Copyright © 2020 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu